WO2025223951 - VERFAHREN ZUR DURCHFÜHRUNG EINER NUKLEINSÄUREAMPLIFIKATION MIT EINER MIKROFLUIDISCHEN VORRICHTUNG

National phase entry is expected:
Publication Number WO/2025/223951
Publication Date 30.10.2025
International Application No. PCT/EP2025/060462
International Filing Date 16.04.2025
Title **
[German] VERFAHREN ZUR DURCHFÜHRUNG EINER NUKLEINSÄUREAMPLIFIKATION MIT EINER MIKROFLUIDISCHEN VORRICHTUNG
[English] METHOD FOR CARRYING OUT NUCLEIC ACID AMPLIFICATION USING A MICROFLUIDIC DEVICE
[French] PROCÉDÉ D'AMPLIFICATION D'ACIDES NUCLÉIQUES À L'AIDE D'UN DISPOSITIF MICROFLUIDIQUE
Applicants **
ROBERT BOSCH GMBH
Inventors
KULICK, Stefan
HAHN, Anna-Lina
FRENZEL, Katharina
OELKRUG, Viktoria
Priority Data
102024203938.1   26.04.2024   DE
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting1994
EPO Filing, Examination, Granting8159
Japan Filing, Examination, Granting2140
South Korea Filing, Examination, Granting1989
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 19,022
Contact Us
Abstract[German] Die Erfindung betrifft ein Verfahren (500) zur Durchführung einer Nukleinsäureamplifikation, insbesondere einer isothermalen Nukleinsäureamplifikation, mit einer mikrofluidischen Vorrichtung (100), insbesondere unter Ausnutzung einer PCR-Architektur (101, 102).[English] The invention relates to a method (500) for carrying out nucleic acid amplification, in particular an isothermal nucleic acid amplification, using a microfluidic device (100), in particular using a PCR architecture (101, 102).[French] L'invention concerne un procédé (500) pour effectuer une amplification d'acides nucléiques, en particulier une amplification isotherme d'acides nucléiques, à l'aide d'un dispositif microfluidique (100), en particulier à l'aide d'une architecture PCR (101, 102).

Rejoining the server...